Cargando…
Identification of microR-106b as a prognostic biomarker of p53-like bladder cancers by ActMiR
Bladder cancers can be categorized into subtypes according to gene expression patterns. P53-like muscle-invasive bladder cancers are generally resistant to cisplatin-based chemotherapy, but exhibit heterogeneous clinical outcomes with a prognosis intermediate to that of the luminal and basal subtype...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212417/ https://www.ncbi.nlm.nih.gov/pubmed/29970902 http://dx.doi.org/10.1038/s41388-018-0367-0 |